Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2009-08-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.0903691106PMID 19651612PMCID PMC2722313
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• NEURON-TO-GLIA TRANSMISSION OF ALPHA-SYNUCLEIN CAUSES GLIAL INCLUSION FORMATION AND IMMUNE RESPONSES IN SYNUCLEINOPATHIES

  2009cited by this paper
• Propagation of Tau Misfolding from the Outside to the Inside of a Cell*

  2009cited by this paper
• α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity

  2009cited by this paper
• Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates

  2009cited by this paper
• Parkinson's disease: from monogenic forms to genetic susceptibility factors.

  2009cited by this paper
• The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease.

  2008cited by this paper
• Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

  2008cited by this paper
• Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein.

  2008cited by this paper
• Origins and effects of extracellular alpha-synuclein: implications in Parkinson's disease.

  2008cited by this paper
• Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years

  2008cited by this paper
• Research in motion: the enigma of Parkinson's disease pathology spread

  2008cited by this paper
• Controlling the mass action of α‐synuclein in Parkinson’s disease

  2008cited by this paper
• Clearance and deposition of extracellular alpha-synuclein aggregates in microglia.

  2008cited by this paper
• Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease

  2008influential reference
• Transplanted dopaminergic neurons develop PD pathologic changes: A second case report

  2008cited by this paper
• Neuronal and glial accumulation of alpha- and beta-synucleins in human lipidoses.

  2007cited by this paper
• Neuronal and glial accumulation of α- and β-synucleins in human lipidoses

  2007cited by this paper
• Origins and Effects of Extracellular α-synuclein: Implications in Parkinson’s Disease

  2007cited by this paper
• Exogenous Induction of Cerebral ß-Amyloidogenesis Is Governed by Agent and Host

  2006cited by this paper
• Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase

  2006cited by this paper
• The biochemistry of Parkinson's disease.

  2005cited by this paper
• Intravesicular Localization and Exocytosis of α-Synuclein and its Aggregates

  2005cited by this paper
• Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway.

  2004cited by this paper
• The cell biology of lysosomal storage disorders

  2004cited by this paper
• Clearance of α-Synuclein Oligomeric Intermediates via the Lysosomal Degradation Pathway

  2004cited by this paper
• Neuronal accumulation of &agr;- and &bgr;-synucleins in the brain of a GM2 gangliosidosis mouse model

  2003cited by this paper
• Neuronal accumulation of alpha- and beta-synucleins in the brain of a GM2 gangliosidosis mouse model.

  2003cited by this paper
• The role of α-synuclein in Parkinson's disease: insights from animal models

  2003cited by this paper
• Molecular Pathways of Neurodegeneration in Parkinson's Disease

  2003cited by this paper
• The role of alpha-synuclein in Parkinson's disease: insights from animal models.

  2003cited by this paper
• Parkinson's Disease Mechanisms and Models

  2003cited by this paper
• Staging of brain pathology related to sporadic Parkinson's disease.

  2003cited by this paper
• Differential neuropathological alterations in transgenic mice expressing α‐synuclein from the platelet‐derived growth factor and Thy‐1 promoters

  2002cited by this paper
• Formation and Removal of α-Synuclein Aggregates in Cells Exposed to Mitochondrial Inhibitors*

  2002cited by this paper
• The neuropathogenic contributions of lysosomal dysfunction

  2002cited by this paper
• Formation and removal of alpha-synuclein aggregates in cells exposed to mitochondrial inhibitors.

  2002cited by this paper
• Transmissible spongiform encephalopathies, amyloidoses and yeast prions: Common threads?

  2000cited by this paper
• alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.

  1998cited by this paper
• α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies

  1998cited by this paper
• Neuropathology of Parkinson's Disease

  1996cited by this paper
• [Biochemistry of Parkinson's disease].

  1988cited by this paper

• Anti-TLR2 immunotherapy modulates neuron-to-oligodendrocyte propagation of α-synuclein in mouse and human models

  2026cites this paper
• In situ NMR and integrative proteomics reveal the interaction signature of serum α-synuclein.

  2026cites this paper
• Decoding synaptic imbalance in neurodegenerative diseases: From pathological analysis to targeted intervention.

  2026cites this paper
• Impairment in stimulus-response learning as a cognitive biomarker in a model of synucleinopathy

  2026cites this paper
• Bridging pathway dysfunction and therapy: novel compounds for neuroprotection

  2026cites this paper
• Abnormal Large-Scale Dynamic Brain Networks in Parkinson’s Disease With Cognitive Impairment: Insights From EEG Co-Activation Patterns

  2025cites this paper
• A novel lncRNA FAM151B-DT regulates autophagy and degradation of aggregation prone proteins

  2025cites this paper
• M14 substitutions in exanatide modulate alpha‐synuclein aggregation

  2025cites this paper
• Distinct alpha-synuclein strains derived from Parkinson’s disease patient tissues trigger differential inclusion pathology in a novel biosensor cell model

  2025cites this paper
• MicroRNAs and synaptic dysfunction in Parkinson’s disease

  2025cites this paper
• Maintenance and Decline of Neuronal Lysosomal Function in Aging

  2025cites this paper
• Lasting Impact: Exploring the Brain Mechanisms that Link Traumatic Brain Injury to Parkinson’s Disease

  2025influential citation
• Redirecting microglia phenotype via inhibition of NFAT1 ameliorates deficits in mouse model of synucleinopathies

  2025influential citation
• Hidden faces of alpha-synuclein: Cryo-EM revelation of fibril polymorphs driven by disease, mutations, and PTMs

  2025cites this paper
• The role of microglia in the prion-like transmission of protein aggregates in neurodegeneration

  2025cites this paper
• Perilla-derived chalcone inhibits α-synuclein fibrillization and prevents aggregate-induced disruption of intracellular α-synuclein conformation in neuronal cells.

  2025cites this paper
• A novel lncRNA FAM151B-DT regulates degradation of aggregation prone proteins

  2025cites this paper
• Incidental vs. Engineered Nanoparticles in Alzheimer's and Parkinson's Disease: Pathological Pathways and Therapeutic Interventions.

  2025cites this paper
• Glycosylation in neuroinflammation: mechanisms, implications, and therapeutic strategies for neurodegenerative diseases

  2025cites this paper
• Monitoring and investigation to control the brain network disease under immunotherapy by using fractional operator

  2025cites this paper
• Novel in situ seeding immunodetection assay uncovers neuronal-driven alpha-synuclein seeding in Parkinson’s disease

  2025cites this paper
• C‐reactive protein‐mediated dementia

  2025cites this paper
• Aggregation and Propagation of α‐Synuclein in Parkinson's Disease: A Bibliometric Perspective

  2025cites this paper
• Female mice exhibit resistance to disease progression despite early pathology in a transgenic mouse model inoculated with alpha-synuclein fibrils

  2025cites this paper
• Systemic delivery of anti-sense oligonucleotide targeting a-synuclein for the treatment of multiple system atrophy

  2025cites this paper
• The epidemiological risk and prevention and interventions in Parkinson's disease: from a nutrition-based perspective.

  2025cites this paper
• Neuropathology of Lewy body dementia: Lewy-related pathology, α-synuclein oligomers, and comorbid pathologies

  2025cites this paper
• Intracellular Transport of Monomeric Peptides, (Poly)Peptide-Based Coacervates and Fibrils: Mechanisms and Prospects for Drug Delivery

  2025cites this paper
• In-silico study of – 39 phytochemicals targeted against micelle-bound and Parkinson’s diseased patient’s ‘α-Synuclein’

  2025cites this paper
• Modeling neuroimmune dynamics in neurodegeneration: A nonlinear ODE framework for stability and transition analysis

  2025cites this paper
• Extracellular vesicles in TDP-43 proteinopathies: pathogenesis and biomarker potential

  2025cites this paper
• MicroRNAs alteration and unique distribution in the soma and synapses of substantia nigra in Parkinson’s disease

  2025cites this paper
• A hypothesis explaining Alzheimer's disease, Parkinson's disease, and dementia with Lewy bodies overlap

  2025cites this paper
• Broken Balance: Emerging Cross-Talk Between Proteostasis and Lipostasis in Neurodegenerative Diseases

  2025cites this paper
• Formation of seeding-competent α-synuclein aggregates in parkin-deficient iPSC-derived human neurons

  2025cites this paper
• Development of an RNA Aptamer as a Therapeutic Agent for Synucleinopathies

  2025cites this paper
• Activation of α7nAch receptors ameliorates α-synuclein pathology in the brain and gut of a subacute MPTP mouse model of Parkinson's disease.

  2025cites this paper
• A novel C. elegans model for MAPT/Tau spreading reveals genes critical for endolysosomal integrity and seeded MAPT/Tau aggregation

  2025cites this paper
• N-Homocysteinylation of lysine residues in α-Synuclein enhances aggregation propensity and cytotoxicity in SH-SY5Y cells

  2025cites this paper
• Design of Ig-like binders targeting α-synuclein fibril for mitigating its pathological activities

  2025cites this paper
• Analytical Review on Normal Brain Aging, Alzheimer’s Disease, and Stage 4S Neuroblastoma: Novel Insights Into Neuroprotection, Neurodegeneration, and Spontaneous Regression

  2025cites this paper
• In vivo and in silico alpha-synuclein propagation dynamics: The role of genotype, epicentre, and connectivity

  2025cites this paper
• Innate Immune Mechanisms in the Central Nervous System.

  2025cites this paper
• Revisiting the advance of age-dependent α-synuclein propagation and aggregation

  2025cites this paper
• Generation of iPSC Lines with Tagged α-Synuclein for Visualization of Endogenous Protein in Human Cellular Models of Neurodegenerative Disorders

  2025cites this paper
• Intracellular Inclusions Induced by Patient-Derived and Amplified α-Synuclein Aggregates Are Morphologically Indistinguishable

  2025cites this paper
• PLK2 disrupts autophagic flux to promote SNCA/α-synuclein pathology

  2025cites this paper
• Internalized SNCA/α-synuclein fibrils become truncated and resist degradation in neurons while glial cells rapidly degrade SNCA fibrils

  2025cites this paper
• Modulation of O-GlcNAc cycling influences α-synuclein amplification, degradation, and associated neuroinflammatory pathology

  2025cites this paper
• Stepwise recruitment of chaperone Hsc70 by DNAJB1 produces ordered arrays primed for bursts of amyloid fibril disassembly

  2025cites this paper
• Skin-derived α-synuclein strains from PD, DLB, and MSA induce distinct intracellular pathology and neurodegeneration

  2025cites this paper
• Rapidly Progressive Multiple System Atrophy—Cerebellar Type in a 52‐Year‐Old Woman: Diagnostic Challenges in a Resource‐Limited Setting

  2025cites this paper
• Gut microbiota and Parkinson’s disease: potential links and the role of fecal microbiota transplantation

  2024cites this paper
• α-Synuclein pathology as a target in neurodegenerative diseases

  2024cites this paper
• Astrocytes contribute to toll-like receptor 2-mediated neurodegeneration and alpha-synuclein pathology in a human midbrain Parkinson’s model

  2024cites this paper
• Exogenous α-Synuclein Induces Oxidative Damage to Dopaminergic Neurons Through p-NMDAR2B/Nur77

  2024cites this paper
• Manganese Exposure Enhances the Release of Misfolded α-Synuclein via Exosomes by Impairing Endosomal Trafficking and Protein Degradation Mechanisms

  2024cites this paper
• The Role of Microglia and Astrocytes in the Pathomechanism of Neuroinflammation in Parkinson's Disease-Focus on Alpha-Synuclein.

  2024cites this paper
• Neuronal constitutive endolysosomal perforations enable α-synuclein aggregation by internalized PFFs

  2024cites this paper
• The potential of exosomal biomarkers: Revolutionizing Parkinson's disease: How do they influence pathogenesis, diagnosis, and therapeutic strategies?

  2024cites this paper
• α-Synuclein disrupts microglial autophagy through STAT1-dependent suppression of Ulk1 transcription

  2024cites this paper
• Role of non-neuronal cells in neurorepair: a focus on proteinopathy and neurodegeneration

  2024cites this paper
• Modulation of cannabinoid receptor 2 alters neuroinflammation and reduces formation of alpha-synuclein aggregates in a rat model of nigral synucleinopathy

  2024cites this paper
• Modulation of cannabinoid receptor 2 alters neuroinflammation and reduces formation of alpha-synuclein aggregates in a rat model of nigral synucleinopathy

  2024cites this paper
• Intercellular transmission of alpha-synuclein

  2024cites this paper
• Microglial and neuronal fates following inhibition of CSF-1R in synucleinopathy mouse model.

  2024cites this paper
• α-Synuclein strain propagation is independent of cellular prion protein expression in a transgenic synucleinopathy mouse model

  2024cites this paper
• Therapeutic Effect of Padina arborescens Extract on a Cell System Model for Parkinson’s Disease

  2024cites this paper
• Role of mitochondria‐endoplasmic reticulum contacts in neurodegenerative, neurodevelopmental and neuropsychiatric conditions

  2024cites this paper
• Alpha-synuclein, autophagy-lysosomal pathway, and Lewy bodies: Mutations, propagation, aggregation, and the formation of inclusions

  2024cites this paper
• Role of the Gut Microbiome and Bacterial Amyloids in the Development of Synucleinopathies (Review)

  2024cites this paper
• Research progress on astrocyte-derived extracellular vesicles in the pathogenesis and treatment of neurodegenerative diseases

  2024cites this paper
• The immune system in Parkinson's disease: what we know so far

  2024cites this paper
• Natural Compounds That Activate the KEAP1/Nrf2 Signaling Pathway as Potential New Drugs in the Treatment of Idiopathic Parkinson’s Disease

  2024cites this paper
• Dendritic cells in Parkinson's disease: regulatory role and therapeutic potential.

  2024cites this paper
• Expression of G2019S LRRK2 in Rat Primary Astrocytes Mediates Neurotoxicity and Alters the Dopamine Synthesis Pathway in N27 Cells via Astrocytic Proinflammatory Cytokines and Neurotrophic Factors

  2024cites this paper
• RGS10 mitigates high glucose-induced microglial inflammation via the reactive oxidative stress pathway and enhances synuclein clearance in microglia

  2024cites this paper
• Nature’s carriers: leveraging extracellular vesicles for targeted drug delivery

  2024cites this paper
• Therapeutic Peptide SS-31 Modulates Membrane Binding and Aggregation of α-Synuclein and Restores Impaired Mitochondrial Function

  2024cites this paper
• Role of the Gut Microbiome and Bacterial Amyloids in the Development of Synucleinopathies

  2024cites this paper
• Sex-focused analyses of M83 A53T hemizygous mouse model with recombinant human alpha-synuclein preformed fibril injection identifies female resilience to disease progression: A combined magnetic resonance imaging and behavioural study

  2024cites this paper
• Oscillations in Neuronal Activity: A Neuron-Centered Spatiotemporal Model of the Unfolded Protein Response in Prion Diseases

  2024cites this paper
• The potential of phosphorylated α‐synuclein as a biomarker for the diagnosis and monitoring of multiple system atrophy

  2024cites this paper
• Gut–Brain Axis in Focus: Polyphenols, Microbiota, and Their Influence on α-Synuclein in Parkinson’s Disease

  2024cites this paper
• Internalized α-synuclein fibrils become truncated and resist degradation in neurons while glial cells rapidly degrade α-synuclein fibrils

  2024cites this paper
• Targets to Search for New Pharmacological Treatment in Idiopathic Parkinson’s Disease According to the Single-Neuron Degeneration Model

  2024cites this paper
• Network spreading and local biological vulnerability in amyotrophic lateral sclerosis

  2024cites this paper
• Molecular properties and diagnostic potential of monoclonal antibodies targeting cytotoxic α-synuclein oligomers

  2024cites this paper
• Low-density lipoprotein receptor–related protein 1 mediates α-synuclein transmission from the striatum to the substantia nigra in animal models of Parkinson’s disease

  2024cites this paper
• The Role of α-Synuclein in Etiology of Neurodegenerative Diseases

  2024cites this paper
• Stem Cell-Based Approaches in Parkinson’s Disease Research

  2024cites this paper
• Characterization of pSer129-αSyn Pathology and Neurofilament Light-Chain Release across In Vivo, Ex Vivo, and In Vitro Models of Pre-Formed-Fibril-Induced αSyn Aggregation

  2024cites this paper
• Widespread Nuclear Lamina injuries defeat proteostatic purposes of α-Synuclein amyloid Inclusions.

  2024cites this paper
• Unlocking the potential of circulating small extracellular vesicles in neurodegenerative disease through targeted biomarkers and advancements in biosensing

  2024cites this paper
• α-Synuclein reduces acetylserotonin O-methyltransferase mediated melatonin biosynthesis by microtubule-associated protein 1 light chain 3 beta-related degradation pathway

  2024cites this paper
• From Synaptic Physiology to Synaptic Pathology: The Enigma of α-Synuclein

  2024cites this paper
• Stepwise recruitment of Hsc70 by DNAJB1 produces ordered arrays primed for bursts of amyloid fibre disassembly

  2024cites this paper
• Constitutive Endolysosomal Perforation in Neurons allows Induction of α-Synuclein Aggregation by Internalized Pre-Formed Fibrils

  2024cites this paper
• Recent advances of nanomaterials for intervention in Parkinson’s disease in the context of anti-inflammation

  2024cites this paper
• Cell-to-cell transmitted alpha-synuclein recapitulates experimental Parkinson’s disease

  2024cites this paper